Product Information
MIRABEGRON ER 50 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $9.3866 per EA under NDC 68180015209. Its NADAC has been published 101 times since Oct 30, 2024.
FDA first approved this application on Sep 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180015209
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRABEGRONApproval Type
Generic (ANDA)
FDA Application
ANDA209485FDA Approved
9/28/2022
TE Code
AB
On Market Since
9/3/2024
Pharmacological Classes
Price Statistics
The NADAC for MIRABEGRON ER 50 MG TABLET has been published 101 times since Oct 30, 2024, and over the history we have for it it has declined 17.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3866 per EA |
|---|---|
| All-time high | $11.3806 (Nov 13, 2024) |
| All-time low | $9.3866 (Sep 23, 2026) |
| 52-week high | $9.7568 |
| 52-week low | $9.3866 |
| Median price | $9.6695 |
| Average price | $9.8582 |
| Largest weekly change | -7.7% (Nov 20, 2024) |
| Weeks tracked | 101 |
| Tracking since | Oct 30, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mirabegron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta3-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRABEGRON ER 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 50 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $9.3866 per EA (NDC 68180015209), effective Sep 30, 2026.
How has the price of MIRABEGRON ER 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRABEGRON ER 50 MG TABLET has declined 17.5%. It has been tracked across 101 weekly CMS publications since Oct 30, 2024.
What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 50 MG TABLET?
Since Oct 30, 2024, the NADAC for MIRABEGRON ER 50 MG TABLET has ranged from a low of $9.3866 (Sep 23, 2026) to a high of $11.3806 (Nov 13, 2024), with a median of $9.6695 per EA.
Are there cheaper alternatives to MIRABEGRON ER 50 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRABEGRON ER 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRABEGRON ER 50 MG TABLET?
MIRABEGRON ER 50 MG TABLET (NDC 68180015209) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.